NEWS & EVENTS 
SPECIALTY CARE
IHI 2025 Poster: Developing a Novel Training Program on Low Carbohydrate Diet Counseling in Type 2 Diabetes Care
Updated: 12/08/25
Citation: Hisamatsu, R, Griauzde, DH, Gabison J, Pilarz S, Monkman L, Brannon E, Young L, Rau J, Oshman L. Developing a Novel Training Program on Low Carbohydrate Diet Counseling in Type 2 Diabetes Care. Institute for Healthcare Improvement Forum 2025. December 8-11, 2025, Anaheim, CA.
Presented at the Institute for Healthcare Improvement (IHI) Forum conference in December 2025, Anaheim, CA.
Poster Title: Developing a Novel Training Program on Low Carbohydrate Diet Counseling in Type 2 Diabetes Care.
DOI: Not Available
Authors: Rina Hisamatsu, MPH, RDN, Dina H. Griauzde, MD, MSc, DABOM, Jonathan Gabison, MD FAAFP DABOM, Stacey Pilarz, RDN, CDCES, Laura K. Monkman, PhD, Elliott Brannon, MD, PhD, MPH, Larrea Young MDes, Jacqueline Rau, MHSA, PMP, Lauren Oshman, MD, MPH
Introduction and Objective: T2D persists at epidemic proportions, and clinicians face ongoing challenges with navigating the complexities of patient care and providing effective treatments to meet patients’ needs.
The Standards of Care published by the American Diabetes Association recommends that all people with T2D receive individualized medical nutrition therapy and endorses low carbohydrate diets (LCDs) as a viable approach in T2D management. However, clinicians report limited training and confidence in discussing LCDs with patients contributing to it being an underutilized treatment approach.
MCT2D developed an interactive LCD training program combining foundational knowledge with practical counseling and implementation strategies to improve clinician confidence in utilizing LCD interventions with their T2D patients. The first offering of this training was held virtually and ran from 5/12/25 - 5/16/25.
Tags: Research, Created By MCT2D
Subscribe to the MCT2D Newsletter
Once per month we deliver news, updates, events, and more directly to you!
ccteam@mct2d.org
Support for The Michigan Collaborative for Type 2 Diabetes (MCT2D) is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program.
Although Blue Cross Blue Shield of Michigan and MCT2D work collaboratively, the opinions, beliefs and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs and viewpoints of BCBSM or any of its employees.